Universal Hospitality Solutions (UHS) Appointed to Manage Crowne Plaza® Dallas Downtown
DALLAS & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Universal Hospitality Solutions (UHS) today announced that the company is managing Crowne Plaza® Dallas Downtown by IHG. Under the management assignment, UHS is responsible for operating the 291-key, high-rise Crowne Plaza to better meet the needs of the modern traveler. UHS is a hotel development and management company that operates several hotels, representing well-known hotel brands in the United States and international locations. The Scottsdale, Arizona-based company provides complete lifecycle services for hotel owners and investors to maximize their hospitality industry-related returns.
Outstanding service is the cornerstone of helping guests make the most of their journeys.
Share
'We appreciate the trust and confidence in our management team's track record for achieving impressive operational and financial results,' said Scott Nadel, CEO of Universal Hospitality Solutions. 'As an experienced hotel development and management company, UHS is committed to delivering on the high expectations of our associates, guests and hotel ownership.'
Downtown Dallas Fixture
Located at 1015 Elm Street, Crowne Plaza Dallas Downtown is a short walk to Kay Bailey Hutchison Convention Center Dallas and over 50 restaurants. The property is near several major employers, local attractions, West End district, American Airlines Center, and Uptown. The hotel is convenient to downtown Dallas public transportation and is approximately seven miles from Dallas Love Field (DAL) and 19 miles from Dallas Fort Worth International Airport (DFW).
With an inviting environment of beauty in balance, Crowne Plaza Dallas Downtown inspires connection and collaboration that improve the well-being of business and leisure guests. A sampling of hotel amenities includes:
Well-appointed guest rooms/suites with amazing views of downtown Dallas, contemporary décor, 55' television, mini refrigerator, desk and ergonomic chair, eco-friendly Apotheke toiletries, and free Wi-Fi access.
Onsite dining options including Thrive Restaurant for breakfast and dinner featuring a refreshed menu with a global twist, including vegetarian options and kids' menu; Thrive Round Bar; and room service.
Fully equipped fitness center, open 24/7.
Conference center with 30,000 square feet of flexible event space; dedicated Crowne Meetings Director; versatile spaces, including combined 11,273 square feet to accommodate a reception of 1,677 guests; onsite catering; and comprehensive multimedia and audio-visual support.
Business center, open 24/7.
Ninth-floor rooftop pool with panoramic views of downtown Dallas skyline.
Onsite self-service laundry.
Onsite parking garage and valet service.
Immediate Improvements
According to Nadel, UHS is currently implementing several property updates at Crowne Plaza Downtown Dallas, such as:
Refreshing menu offerings to appeal to travelers from around the world, including Mediterranean Shrimp Pasta, Chimichurri Filet, Tuscan Chicken Flatbread, and Vegetarian Omelet.
Upgrading bedding in the hotel's 291 guest rooms/suites.
Recarpeting all guest floor corridors in a calming shade of blue complemented by earthy tones of tan and beige.
Converting the hotel's onsite snack bar/deli to The MarketPlace, a convenient, 24/7 spot for purchasing snacks and sundries.
Culture Cornerstone
According to Nadel, outstanding service is the cornerstone of helping guests make the most of their journeys. Nadel said, 'Our associates are at the core of our successful hotel operations leading to repeat guest stays. If we properly take care of our associates and provide them with training and meaningful opportunities for growth and well-being, they will take care of our guests.' For more information about joining the team at Crowne Plaza Dallas Downtown, please contact UHS.
Crowne Plaza Dallas Downtown is an active community partner by:
Supporting local businesses, including nearby restaurants, artisans and tour operators.
Hiring locally and offering training with an emphasis on underrepresented groups.
Volunteering time and resources to impactful causes, such as community cleanup days, charity events, school and foodbank donations, and youth sports team sponsorships.
Collaborating with local environmental groups to reduce waste and to source supplies locally.
Crowne Plaza Dallas Downtown participates in IHG One Rewards loyalty program, providing hotel rewards and exclusive member offers. For more information about Crowne Plaza Dallas Downtown or to make a reservation, visit the hotel's website or call (214) 742-5678. For sales and events, please contact UHS.
About Universal Hospitality Solutions
Scottsdale, Arizona-based Universal Hospitality Solutions provides complete lifecycle services for hotel owners and investors to maximize their hospitality industry-related returns. With over 40 years combined experience developing and managing hotels, UHS' partners have the deep insight into market conditions, construction, forecasting, sales and marketing, operations, staffing, management, hotel brands, and other areas necessary to maximize the revenue and profitability for any hotel project at any phase in its lifecycle. For hotel owners or operators looking to take their business to the next level through strategic partnerships, please contact UHS.
As one of the world's largest premium hotel brands with locations in city, airport, resort and suburban destinations, Crowne Plaza is perfectly placed to meet the needs of today's guest, whether they are traveling for business, leisure, or a blend of both. For more information, visit www.crowneplaza.com, and connect with us on Facebook and Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
30 minutes ago
- Business Insider
Diabetes startup Omada Health finally went public after 14 years. Here's who made bank.
Omada Health just became the second digital health company to IPO this year. The chronic care company saw its shares jump Friday morning by over 38% above its initial price. Here's what Omada's major investors' stakes are worth after the public market debut. Omada Health just went public at a $1.1 billion valuation — 14 years after its founding. It's the second digital health IPO of the year, following physical therapy company Hinge Health, which went public on May 21. The two IPOs come after a multiyear drought for healthcare public market debuts. And so far, Omada's IPO hasn't disappointed. While the chronic care company priced its initial shares at $19, its stock opened at $23 a share and jumped as high as $28.40 Friday morning, nearly a 50% increase. Omada Health launched in 2011 to provide virtual care for prediabetes, making its name in the years following for diabetes management. In recent years, its business has surged in new areas beyond diabetes care. Omada's weight care business has boomed as more patients taking GLP-1 drugs like Ozempic for weight loss seek companion care. The San Francisco-based company says most of its new employer and health plan clients approach Omada initially, interested in its metabolic health track. Omada's initial valuation of $1.1 billion is roughly where it was privately valued. Omada's last private fundraise, a $192 million Series E round announced in February 2022, put Omada's valuation over $1 billion. It's perhaps the best outcome Omada's investors could've hoped for, given that many digital health startups now looking to IPO last raised at huge valuations during VC's ZIRP period. Those valuations could be difficult to realize in today's market. Hinge Health, for example, went public at a $2.6 billion valuation after being valued in its 2021 fundraise at $6.2 billion. We don't know what Omada Health's investors paid for their shares, so we can't calculate their profit. However, since Omada's shares opened on the stock market at $23, we used that price to determine the worth of its investors' stakes. None of Omada's major investors sold any shares in its IPO. Here's what the stakes of Omada Health's major investors and executives are worth after its IPO. Revelation Partners is a healthcare-focused investment firm that says it provides flexible capital to companies, especially to give liquidity to startups. The firm first invested in Omada in September 2019, according to its website. Revelation Partners told Business Insider in an email that the firm invested in Omada through a series of secondary transactions. Omada hasn't mentioned Revelation Partners in previous press releases about its fundraises. Revelation Partners owns about 5.2 million shares, or 9.3% of the company. At the $23 market debut price, the firm's stake is worth about $120 million. US Venture Partners, an investor: $108.5 million San Francisco-based US Venture Partners makes early-stage investments across healthcare, software, consumer, and security. The firm says it's invested $4.5 billion across 532 companies. USVP led Omada Health's $4.7 million Series A fundraise in 2013. The firm contributed additional financing in Omada's Series B through D rounds. General partner Dr. Jonathan Root has served on Omada's board of directors since the firm's 2013 investment. USVP owns about 4.72 million shares, or 8.5% of Omada Health. At the $23 market debut price, the firm's stake is worth about $108.5 million. Andreessen Horowitz, an investor: $106 million VC giant Andreessen Horowitz, or A16z, first invested in Omada Health in 2015, when the firm led Omada's $23 million Series B. The firm went on to invest in Omada's Series C and D fundraises, per PitchBook. At the time of A16z's 2015 investment, former general partner Balaji Srinivasan joined Omada's board of directors. It's unclear when he stepped down from the board; he moved into a part-time role at A16z that same year. A16z owns about 4.6 million shares, or 8.3% of the company. At the $23 market debut price, the firm's stake is worth about $106 million. Fidelity Management and Research Company, an investor: $102 million Fidelity Management and Research Company is the parent company of financial services giant Fidelity Investments. Fidelity has invested in a handful of healthcare startups over the years, leading rounds like now- public insurtech Oscar Health 's $400 million raise in 2016 and smart ring maker Oura 's $200 million Series D in December. FMR led Omada's $192 million Series E fundraise in February 2022. Fidelity owns about 4.4 million shares, or 8.0% of the company. At the $23 market debut price, the firm's stake is worth about $102 million. Cigna Ventures, an investor: $79 million Health insurance giant Cigna spun out a venture capital arm in 2018 to back healthcare companies. Omada Health was one of the firm's first bets. Cigna began working with the diabetes company in 2015. Two years later, the insurer announced an investment in Omada, leading a $50 million round in 2017 that Cigna Ventures later called Omada's Series C-1 financing. Cigna also expanded its partnership with Omada as part of its formal investment. Cigna Ventures owns about 3.4 million shares, or 6.2% of the company. At the $23 market debut price, the firm's stake is worth about $79 million. aMoon Fund, an investor: $62 million Israeli VC firm aMoon fund invests in healthcare and life sciences companies from early to late stages. Founded in 2016, it has backed a number of biotech companies that later went public, including Sophia Genetics, which went public in 2021, and Amylyx Pharmaceuticals, which went public in 2022. The firm first invested in Omada Health in its $192 million Series E round in 2022. "The entire space of all these clusters of diseases that includes diabetes, hypertension, and obesity is going through a major revolution right now," aMoon Fund managing partner Tomer Berkowitz told BI. "The solution in the end will not just be based on drugs, but it'll be a combination of drugs and behavioral change. I think Omada plays a significant role in that." aMoon owns about 2.7 million shares, or 4.9% of the company. At the $23 market debut price, the firm's stake is worth about $62 million. Norwest Venture Partners, an investor: $58 million San Francisco-based Norwest Venture Partners invests in early- to late-stage startups. It's backed more than 700 companies and manages over $15.5 billion in assets, per the firm. Its healthcare portfolio also includes hospital operations AI company Qventus, which raised $105 million in January led by private equity firm KKR, and behavioral health site Talkspace, which went public in a 2021 SPAC deal. The firm led Omada's $48 million Series C round in 2015 and put additional funding into Omada's Series C-1 and D rounds. Norwest owns about 2.5 million shares, or 4.5% of the company. At the $23 market debut price, the firm's stake is worth about $58 million. Sean Duffy, CEO: $46 million Sean Duffy cofounded Omada Health alongside Adrian James, Omada's former president, and Andrew DiMichele, former chief technology officer, in 2011. The startup sought to use technology to deliver care for chronic conditions, initially focusing on prediabetes, to patients in between visits with their primary care providers. Duffy and James spun Omada out of the design and consulting firm IDEO, where they'd begun researching the challenges in prediabetes and metabolic disease care. For Duffy, the IDEO gig had begun as an internship while he was getting dual MD-MBA degrees at Harvard. Instead of returning to complete his studies, he turned his focus to the idea that would become Omada. Before Omada, Duffy had created the interactive Microsoft Excel training tool Excel Everest, written about healthcare innovation for the medtech blog Medgadget, and worked in people analytics at Google. Duffy owns about 2 million shares, or 3.5% of Omada Health. That number includes about 860,000 shares of common stock and 1.15 million stock options exercisable by May 30, according to Omada's S-1 filing. At the $23 market debut price, his stake is worth about $46 million. Wei-Li Shao, president: $13 million Wei-Li Shao has served as Omada's president since 2021. He first joined the company in 2021 as its chief commercial officer. Before Omada, Li spent a combined 17 years at Eli Lilly managing a number of the pharma giant's businesses and brands, including its Alzheimer's disease, diabetes, and neurosciences businesses. Shao owns about 579,095 stock options exercisable by May 30, representing 1.0% of the company. He does not own any common stock. At the $23 market debut price, his stake is worth about $13 million. Steve Cook, CFO: $7.9 million Steve Cook joined Omada Health as its chief financial officer in 2021. He'd previously led strategic finance efforts at primary care chain One Medical through its 2020 IPO. Before that, he spent six years in finance and strategy at Salesforce. Cook owns about 340,000 stock options exercisable by May 30, giving him less than 1% ownership. He does not own any shares of common stock. At the $23 market debut price, his stake is worth about $7.9 million. Trevor Fetter, board member: $5.3 million Trevor Fetter has served on Omada's board of directors since March 2021. He's a senior lecturer at Harvard University and the lead independent director of insurance business The Hartford. Fetter is best known as the former chairman and CEO of health system giant Tenet Healthcare, a position he held for 15 years. Fetter also holds advisory positions at multiple other private and public companies, sitting on the board of directors at healthtech startup Biofourmis and serving as a member of the advisory board of private equity firm TowerBrook Capital Partners. Fetter owns about 231,000 shares, or less than 1% of the company. That number includes about 111,000 shares of common stock and 120,000 stock options exercisable by May 30. At the $23 market debut price, his stake is worth about $5.3 million. Jeryl Hilleman, chair of the board of directors: $4.8 million Jeryl Hilleman has spent the majority of her career as a serial CFO, holding the lead finance role at five different companies across industries, including software, biotech, and medtech. All five companies were ultimately acquired. Today, Hilleman is the chair of Omada's board of directors, a position she's held since 2019. She also serves on the boards of cancer therapeutics maker Novocure, which completed its IPO in February, as well as public medtech company Si-Bone and public vaccine maker HilleVax. Hilleman owns about 210,000 stock options exercisable by May 30, which gives her less than 1% ownership of Omada. She does not own any common stock. At the $23 market debut price, her stake is worth about $4.8 million. Dr. Sachin Jain, board member: $604,000 Dr. Sachin Jain is the president and CEO of Medicare Advantage provider SCAN Health Plan. He joined Omada's board of directors in August. Jain is also a professor of medicine at Stanford and a practicing academic hospitalist at the US Department of Veterans Affairs. Previously, he was a senior advisor to the administrator of the Centers for Medicare and Medicaid Services, the president and CEO of CareMore Health and Aspire Health, and the chief medical information and innovation officer at Merck. Jain owns about 26,000 stock options exercisable by May 30, representing less than 1% of the company. He does not own any common stock. At the $23 market debut price, his stake is worth about $604,000. Julie Klapstein, board member: $527,000 Omada Health added Julie Klapstein to its board of directors in August. Klapstein was the founding CEO of Availity, one of the largest health information networks in the country. She spent nearly 11 years at Availity after its 2001 founding. Since Availity, she's served as a board member at nearly two dozen public and private companies, including healthcare companies like value-based primary care chain Oak Street Health and investment firms like PE firm Riverside Partners. She's also been an advisor to Andreessen Horowitz, most recently serving as a partner advisor from 2023 through April, per her LinkedIn. Klapstein owns about 23,000 stock options exercisable by May 30, representing less than 1% of the company. She does not own any common stock. At the $23 market debut price, her stake is worth about $527,000. Adam Stavisky, board member: $527,000 Omada added Adam Stavisky to its board of directors in August, alongside Klapstein and Jain. He most recently spent six years as the senior vice president of US benefits at Walmart. Before that, he spent 13 years at Fidelity, leaving as its head of benefits consulting. In addition to his role at Omada, he's a member of the board of advisors at marketing agency StrawberryFrog. Stavisky owns about 23,000 stock options exercisable by May 30, representing less than 1% of Omada Health. He does not own any common stock. At the $23 market debut price, his stake is worth about $527,000. Dr. Anne Beal, board member: $380,000 Omada added Dr. Anne Beal to its board of directors in October. Beal is the founder of AbsoluteJOI Skincare, a science-based clean beauty company. She's also a board member at pharma giant GSK and life sciences company Prolacta Biosciences. She previously served as the chief patient officer at biopharma behemoth Sanofi. Beal owns about 17,000 stock options exercisable by May 30, representing less than 1% of Omada Health. She does not own any common stock.
Time Business News
30 minutes ago
- Time Business News
SyntecBiofuel Plans to Open New Lab in Asia
Syntecbiofuel Strategic investment in microbial biofuel technology aims to accelerate Asia's clean energy transition and strengthen global supply chains SyntecBiofuel, a global leader in sustainable biofuel innovation, today announced the establishment of a new state-of-the-art research and development laboratory in Asia [location TBD, e.g., Singapore or South Korea]. This expansion underscores SyntecBiofuel's commitment to revolutionizing biofuel production through synthetic biology and scaling sustainable solutions tailored for the rapidly growing Asian market. The strategic move aligns with the region's accelerating focus on decarbonization and renewable energy adoption. The new lab will leverage Asia's abundant biomass feedstocks and foster collaboration with local academic institutions and industry partners to drive breakthroughs in microbial biofuel technology. 'Our mission is to bridge synthetic biology innovations with scalable biofuel solutions that meet global sustainability goals,' said [CEO Name], CEO of SyntecBiofuel. 'Asia's vibrant innovation ecosystem is pivotal in achieving net-zero targets worldwide, and this lab will serve as a catalyst for delivering affordable, carbon-neutral biofuels to one of the world's fastest-growing energy markets.' The lab's core research initiatives will focus on metabolic engineering, waste-to-fuel conversion technologies, and optimizing biofuel yield and efficiency. These efforts aim to reduce production costs and enable the deployment of sustainable aviation fuel (SAF) and bio-gasoline tailored for the Asian market. SyntecBiofuel plans to launch the facility by [expected opening date], with a hiring initiative to recruit leading scientists and engineers in bioenergy and synthetic biology. The company invites strategic partnerships with investors, policymakers, and green technology collaborators to accelerate the transition to a sustainable energy future. Founded in [Year], SyntecBiofuel is a UK-based clean technology company pioneering advanced biofuel solutions. Backed by multiple patents and successful commercial deployments, SyntecBiofuel delivers innovative, sustainable fuels that reduce carbon emissions and support the circular economy. Media Contact Get in Touch with SyntecBiofuel's Media Relations Team For all press inquiries, interview requests, or media partnerships, please contact: Follow Us Online Stay updated on the latest news, innovations, and events from SyntecBiofuel: TIME BUSINESS NEWS
Yahoo
38 minutes ago
- Yahoo
Wright One Selects Bridgeport as Manufacturing Hub for U.S.-Made Climate Tech
Bridgeport, Connecticut--(Newsfile Corp. - June 6, 2025) - Wright One, a climate-focused hardtech startup, today announced it has selected Bridgeport, Connecticut, as its official US manufacturing hub and secured multiple take-or-pay agreements ahead of its August 2025 product launch. This announcement marks a significant step forward in reshoring advanced manufacturing and scaling sustainable infrastructure technologies in the United States. Justin McAfee, founder and CEO of Wright One To view an enhanced version of this graphic, please visit: Founded by mechanical engineer and commercial pilot Justin McAfee, Wright One is preparing for the mass production of its flagship product, the Wright Fan, a modular aviation-grade cooling system designed for industrial applications such as data centers and cryptocurrency mining facilities. These take-or-pay agreements ensure baseline demand for the Wright Fan and represent early customer confidence in the company's modular approach to climate technology. The Wright Fan is designed to reduce costs by up to 50% over a 5-year operating cycle, accounting for labor, disposal fees, and fan replacement costs. Additionally, it features a patented power-switch intended to enable zero-downtime operation. According to company data, the product is expected to reduce lifecycle CO₂e emissions by approximately 85%, with a 40% reduction in CO₂e achieved through recycling of its modular components. The decision to manufacture in Bridgeport leverages the city's industrial legacy and existing infrastructure, aligning with Wright One's mission to revitalize American manufacturing and reduce lifecycle emissions across its product lines. "We're proud to establish our manufacturing base in Bridgeport," said Justin McAfee, founder and CEO of Wright One. "These agreements validate both market demand and the scalability of our technology. With Bridgeport as our foundation, we're building more than products. We're building resilience into the American supply chain." The company's manufacturing facility in Bridgeport will handle assembly, testing, and refurbishment of components, laying the groundwork for a circular economy model that reduces waste and improves operational efficiency. With initial production underway and a growing roster of industrial clients, Wright One is on track to deliver its first commercial units in Q3 2025. About Wright OneWright One is a US-based hardtech company focused on climate-aligned solutions for aviation and infrastructure. By combining modular design with domestic manufacturing and refurbishment, the company aims to reduce emissions, improve reliability, and strengthen the American supply chain. Media Contact:Company: Wright One justin@ Bridgeport, CT To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
